Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma

ConditionNasopharyngeal Carcinoma

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-80

SponsorJiangsu Cancer Institute & Hospital

About this trial

This clinical research aims to explore potential biomarkers and validate molecular signatures' predictive and prognostic value in nasopharyngeal carcinoma.

Eligibility criteria

Qualifiers

Patients with newly histologically confirmed nasopharyngeal carcinoma

No evidence of distant metastasis (M0)

Written informed consent

Disqualifiers

None

Trial design

Treatments tested in this trial

Intensity modulated radiation therapy (IMRT) combined with chemotherapy

Treatment groups

60 Participants

are divided into 1 treatment group

Sponsors and collaborators

Jiangsu Cancer Institute & Hospital

Lead sponsor

Source ClinicalTrials.gov